
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy.
Journal: Molecular cancer therapeutics
Published: May 28, 2025
MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy.
Journal: Molecular cancer therapeutics
Published: May 28, 2025
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.
Journal: Cancers
Published: April 29, 2022
PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
Journal: Hematology/oncology and stem cell therapy
Published: February 13, 2022
Duodenal and Biliary Obstruction due to Extrinsic CompressionDuodenal and Biliary Obstruction due to Extrinsic Compression by Recurrent Lobular Breast Carcinoma: A Case Report.
Journal: Case reports in gastroenterology
Published: July 19, 2021
Neuroendocrine Tumors Are Enriched in Cowden Syndrome.
Journal: JCO precision oncology
Published: April 27, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
Journal: Breast cancer research and treatment
Published: March 02, 2020
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 30, 2019
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2018
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 17, 2018
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Journal: Breast cancer research : BCR
Published: November 07, 2016
Last Updated: 09/26/2026